BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 27778440)

  • 1. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
    De Gottardi A; Trebicka J; Klinger C; Plessier A; Seijo S; Terziroli B; Magenta L; Semela D; Buscarini E; Langlet P; Görtzen J; Puente A; Müllhaupt B; Navascuès C; Nery F; Deltenre P; Turon F; Engelmann C; Arya R; Caca K; Peck-Radosavljevic M; Leebeek FWG; Valla D; Garcia-Pagan JC;
    Liver Int; 2017 May; 37(5):694-699. PubMed ID: 27778440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
    Serrao A; Merli M; Lucani B; Aprile F; Fiori L; Gioia S; Breccia M; Riggio O; Chistolini A
    Eur J Clin Invest; 2021 Jan; 51(1):e13356. PubMed ID: 33180323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.
    Riva N; Ageno W; Poli D; Testa S; Rupoli S; Santoro R; Lerede T; Piana A; Carpenedo M; Nicolini A; Ferrini PM; Tosetto A; ;
    J Thromb Haemost; 2015 Jun; 13(6):1019-27. PubMed ID: 25845412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis.
    Hum J; Shatzel JJ; Jou JH; Deloughery TG
    Eur J Haematol; 2017 Apr; 98(4):393-397. PubMed ID: 28009449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis.
    Caiano LM; Riva N; Ageno W
    Expert Rev Hematol; 2023 Feb; 16(2):121-129. PubMed ID: 36820873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
    Darius H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to manage splanchnic vein thrombosis in patients with liver disease.
    Riva N; Ageno W
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):281-288. PubMed ID: 38066910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K; Góralczyk T; Undas A
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants in patients with liver cirrhosis: A systematic review.
    Hoolwerf EW; Kraaijpoel N; Büller HR; van Es N
    Thromb Res; 2018 Oct; 170():102-108. PubMed ID: 30153564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.
    Ageno W; Riva N; Schulman S; Beyer-Westendorf J; Bang SM; Senzolo M; Grandone E; Pasca S; Di Minno MN; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Oh D; D'Amico E; Becattini C; De Stefano V; Vidili G; Vaccarino A; Nardo B; Di Nisio M; Dentali F
    JAMA Intern Med; 2015 Sep; 175(9):1474-80. PubMed ID: 26168152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art.
    Monaco G; Bucherini L; Stefanini B; Piscaglia F; Foschi FG; Ielasi L
    World J Gastroenterol; 2023 Sep; 29(33):4962-4974. PubMed ID: 37731994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis.
    Weinberg EM; Palecki J; Reddy KR
    Semin Liver Dis; 2019 May; 39(2):195-208. PubMed ID: 30978730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" Experience.
    Rupoli S; Fiorentini A; Morsia E; Svegliati-Baroni G; Micucci G; Maroni L; Garvey KB; Fiorentini A; Riva A; Da Lio L; Benedetti A; Offidani M; Olivieri A; Giuseppe T
    Vasc Health Risk Manag; 2021; 17():619-629. PubMed ID: 34594107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
    Chun HS; Choe AR; Lee M; Cho Y; Kim HY; Yoo K; Kim TH
    Clin Mol Hepatol; 2021 Oct; 27(4):535-552. PubMed ID: 34130370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.
    Semmler G; Lindorfer A; Schäfer B; Bartl S; Hametner-Schreil S; Gensluckner S; Balcar L; Pomej K; Lampichler K; Trauner M; Aigner E; Datz C; Zoller H; Hofer H; Schöfl R; Mandorfer M; Reiberger T; Scheiner B
    Clin Gastroenterol Hepatol; 2023 Apr; 21(4):978-987.e2. PubMed ID: 35533994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis.
    Menichelli D; Ronca V; Di Rocco A; Pignatelli P; Marco Podda G;
    Eur J Clin Invest; 2021 Mar; 51(3):e13397. PubMed ID: 32895926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
    Li Z; Xu W; Wang L; Chai L; Ageno W; Romeiro FG; Li H; Qi X
    Thromb Haemost; 2023 Nov; 123(11):1072-1088. PubMed ID: 37336474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
    Zhou H; Wu M; Yu S; Xia H; Yu W; Huang K; Chen Y
    BMC Gastroenterol; 2023 Sep; 23(1):329. PubMed ID: 37749527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
    Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby IL; Kapraali M; Kechagias S; Lindahl TL; Almer S
    Thromb Res; 2014 Aug; 134(2):455-61. PubMed ID: 24913997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
    Artaza T; Lopes M; Romero M; Gómez AZ; de la Cruz G; Sánchez JJ; González C; Gómez R
    Gastroenterol Hepatol; 2018 Dec; 41(10):611-617. PubMed ID: 30049580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.